Cybin Announces Publication of Sponsored Feasibility Study Validating Kernel’s Flow1 Neuroimaging Technology Measuring Psychedelic Effects on the Brain

Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, commends Kernel, a leader in non-invasive neuroimaging, on their publication titled “Measuring acute effects of…

Read MoreCybin Announces Publication of Sponsored Feasibility Study Validating Kernel’s Flow1 Neuroimaging Technology Measuring Psychedelic Effects on the Brain

Pioneering Technologies in Minimally Invasive Surgery by Topcon Corporation, Olympus Corporation, and Leica Microsystems Propel Growth in Global Surgical Stapling Devices Market – ResearchAndMarkets.com

The “Surgical Stapling Devices Market Size, Share & Trends Analysis Report By Product (Powered, Manual), By Type (Disposable, Reusable), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global surgical stapling…

Read MorePioneering Technologies in Minimally Invasive Surgery by Topcon Corporation, Olympus Corporation, and Leica Microsystems Propel Growth in Global Surgical Stapling Devices Market – ResearchAndMarkets.com

LinkinVAX Completes First Batch Production of “PanCov”, Its Next Generation Multi-variant Vaccine Against Covid and Other Coronaviruses

LinKinVax, a clinical-stage biotechnology company, announced the manufacture and bottling of a GMP batch of its next generation pan-sarbecovirus vaccines, known as PanCov, designed to prevent COVID-19 and other known coronavirus diseases. This new protein-based vaccine is unique because it targets…

Read MoreLinkinVAX Completes First Batch Production of “PanCov”, Its Next Generation Multi-variant Vaccine Against Covid and Other Coronaviruses

United States Remote Patient Monitoring Market Outlook & Forecast Report 2023-2028: Enhancing Patient Care – Manufacturers Focus on RPM Software & Apps – ResearchAndMarkets.com

The “U.S. Remote Patient Monitoring Market – Industry Outlook & Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The U.S. remote patient monitoring market is expected to reach a value of $25.28 billion by 2028 from $13.4 billion in 2022, growing at a…

Read MoreUnited States Remote Patient Monitoring Market Outlook & Forecast Report 2023-2028: Enhancing Patient Care – Manufacturers Focus on RPM Software & Apps – ResearchAndMarkets.com

Nalu Medical, Inc. Presents Important New Clinical Data for PNS and SCS at ASPN 2023

Nalu Medical, Inc. (“Nalu”), a Carlsbad, California-based neurostimulation company that has miniaturized neurostimulation implants for the management of chronic intractable pain for both Peripheral Nerve Stimulation (PNS) and Spinal Cord Stimulation (SCS) indications, presented significant new data from several studies…

Read MoreNalu Medical, Inc. Presents Important New Clinical Data for PNS and SCS at ASPN 2023

Novartis will appeal to U.S. Court of Appeals to uphold validity of Entresto® combination patent; maintains 2023 guidance and mid-term outlook

Novartis today announced that the U.S. District Court for the District of Delaware issued a negative decision regarding the validity of a patent covering Entresto and combinations of sacubitril and valsartan, which expires in 2025 with its pediatric exclusivity. Novartis…

Read MoreNovartis will appeal to U.S. Court of Appeals to uphold validity of Entresto® combination patent; maintains 2023 guidance and mid-term outlook

Baxter Launches Progressa+ Next Gen ICU Bed to Help Address Complex Critical Care Needs

Baxter International Inc. (NYSE:BAX), an innovator in connected beds for med-surg and the intensive care unit (ICU), announced today the U.S. launch of its new Hillrom Progressa+ bed for the ICU. Progressa+ offers new technology and features that help make it easier for nurses…

Read MoreBaxter Launches Progressa+ Next Gen ICU Bed to Help Address Complex Critical Care Needs

CurvaFix Closes $39 Million Series C Financing Round Led by MVM Partners and Announces CEO Transition

CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the close of a $39 million equity financing led by MVM Partners with participation from Sectoral Asset Management and other existing investors. The company also announced that…

Read MoreCurvaFix Closes $39 Million Series C Financing Round Led by MVM Partners and Announces CEO Transition

DermaSensor Presents Study Results on Melanoma Detection in a Medicare Population at American Dermoscopy Meeting

DermaSensor, a health technology company equipping primary care physicians (PCPs) with a non-invasive device for use in evaluation of suspicious skin lesions, presented to the 11th Annual American Dermoscopy Meeting a sub-analysis of the DERM-ASSESS III study data focusing on…

Read MoreDermaSensor Presents Study Results on Melanoma Detection in a Medicare Population at American Dermoscopy Meeting